Skip to main content

Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?

Publication ,  Journal Article
Kikuchi, R; Shah, NP; Dent, SF
Published in: J Clin Med
March 25, 2020

Cardio-oncology is an emerging field tasked with identifying and treating cancer therapy related cardiac dysfunction (e.g., cytotoxic agents, immunotherapies, radiation, and hormone therapies) and optimizing the cardiovascular health of cancer patients exposed to these agents. Novel cancer therapies have led to significant improvements in clinical outcomes for breast cancer patients. In this article, we review the current literature on assessing cardiovascular risk of breast cancer therapies and discuss strategies (including pharmacological and lifestyle interventions) to prevent cardiovascular toxicity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Med

DOI

ISSN

2077-0383

Publication Date

March 25, 2020

Volume

9

Issue

4

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kikuchi, R., Shah, N. P., & Dent, S. F. (2020). Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime? J Clin Med, 9(4). https://doi.org/10.3390/jcm9040896
Kikuchi, Robin, Nishant P. Shah, and Susan F. Dent. “Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?J Clin Med 9, no. 4 (March 25, 2020). https://doi.org/10.3390/jcm9040896.
Kikuchi, Robin, et al. “Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?J Clin Med, vol. 9, no. 4, Mar. 2020. Pubmed, doi:10.3390/jcm9040896.

Published In

J Clin Med

DOI

ISSN

2077-0383

Publication Date

March 25, 2020

Volume

9

Issue

4

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 1103 Clinical Sciences